Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?

被引：37

作者：

Pfister, R ^{[1
]}

Schneider, CA ^{[1
]}

机构：

[1] Univ Cologne, Innere Med Klin 3, D-50924 Cologne, Germany

来源：

CLINICA CHIMICA ACTA | 2004年 / 349卷 / 1-2期

关键词：

natriuretic peptides; BNP; NT-pro-BNP; heart failure; left ventricular dysfunction; acute coronary syndrome;

D O I：

10.1016/j.cccn.2004.06.018

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

A growing body of literature describes diagnostic and prognostic value of B-type natriuretic peptides (BNP) in cardiac diseases since it was first described in 1988. As BNP is mainly secreted in the left ventricular (LV) myocardium, BNP was found to reflect LV function much better than any other neurohumoral factor. Thus, BNP is recommended as the first noninvasive blood test for determination of cardiac function by some authors. The introduction of fully automated, rapid bioassays for measurement of BNP and the aminoterminal part of its pro-hormone (NT-pro-BNP) made it possible to use the test even in emergency care settings. Here we review the literature with special focus on assessment of BNP and NT-pro-BNP in the following clinical settings: community screening for LV dysfunction, primary diagnosis of heart failure in general practice and emergency department (ED) and risk stratification in cardiac dysfunction and acute coronary syndromes. In addition, we discuss which applications can be recommended for daily clinical use from the cardiologist's point of view. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：25 / 38

页数：14

共 70 条

[1] NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function [J].

Bay, M ;

Kirk, V ;

Parner, J ;

Hassager, C ;

Nielsen, H ;

Krogsgaard, K ;

Trawinski, J ;

Boesgaard, S ;

Aldershvile, J .

HEART, 2003, 89 (02) :150-154

[2] N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction [J].

Bayés-Genís, A ;

Santaló-Bel, M ;

Zapico-Muñiz, E ;

López, L ;

Cotes, C ;

Bellido, J ;

Leta, R ;

Casan, P ;

Ordóñez-Llanos, J .

EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) :301-308

[3] B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].

Berger, R ;

Huelsman, M ;

Strecker, K ;

Bojic, A ;

Moser, P ;

Stanek, B ;

Pacher, R .

CIRCULATION, 2002, 105 (20) :2392-2397

[4] B-type natriuretic peptide and ischemia in patients with stable coronary disease - Data from the Heart and Soul Study [J].

Bibbins-Domingo, K ;

Ansari, M ;

Schiller, NB ;

Massie, B ;

Whooley, MA .

CIRCULATION, 2003, 108 (24) :2987-2992

[5] Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling [J].

Cataliotti, A ;

Malatino, LS ;

Jougasaki, M ;

Zoccali, C ;

Castellino, P ;

Giacone, G ;

Bellanuova, I ;

Tripepi, R ;

Seminara, G ;

Parlongo, S ;

Stancanelli, B ;

Bonanno, G ;

Fatuzzo, P ;

Rapisarda, F ;

Belluardo, P ;

Signorelli, SS ;

Heublein, DM ;

Lainchbury, JG ;

Leskinen, HK ;

Bailey, KR ;

Redfield, MM ;

Burnett, JC .

MAYO CLINIC PROCEEDINGS, 2001, 76 (11) :1111-1119

[6] A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study [J].

Cheng, V ;

Kazanagra, R ;

Garcia, A ;

Lenert, L ;

Krishnaswamy, P ;

Gardetto, N ;

Clopton, P ;

Maisel, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :386-391

[7] Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis [J].

Clerico, A ;

Caprioli, R ;

Del Ry, S ;

Giannessi, D .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (01) :24-30

[8] Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].

Cowie, MR ;

Struthers, AD ;

Wood, DA ;

Coats, AJS ;

Thompson, SG ;

PooleWilson, PA ;

Sutton, GC .

LANCET, 1997, 350 (9088) :1349-1353

[9] PLASMA BRAIN NATRIURETIC PEPTIDE IN ASSESSMENT OF ACUTE DYSPNEA [J].

DAVIS, M ;

ESPINER, E ;

RICHARDS, G ;

BILLINGS, J ;

TOWN, I ;

NEILL, A ;

DRENNAN, C ;

RICHARDS, M ;

TURNER, J ;

YANDLE, T .

LANCET, 1994, 343 (8895) :440-444

[10] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].

de Lemos, JA ;

Morrow, DA ;

Bentley, JH ;

Omland, T ;

Sabatine, MS ;

McCabe, CH ;

Hall, C ;

Cannon, CP ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021

← 1 2 3 4 5 6 7 →